COVID-19 Vaccine
 

Current Eligibility Criteria

Last updated May 13, 2021


Only first-dose appointments are being booked at all locations at this time.




Super-Sites and Pop-up Clinics

 

Current Eligibility:



Book your COVID-19 vaccine appointment online

If you are eligible to be immunized, you can now book your vaccine appointment online for any of our supersites, quickly and conveniently.

To book, you'll need to create an account with your email address and health card number.  You can link more than one person to the same account, so that you can book for family members and loved ones as they become eligible.  Please note that only first-dose appointments should be booked at this time.

Book your COVID-19 vaccine appointment online

Once you have booked an appointment, don’t forget to print and complete your consent form. If you are a senior or have mobility issues and need help getting to your appointment, call 211 for available transportation options in your area.

If you don't have an email address or health card number, the call centre continues to be available at 1-844-626-8222 (1-844-MAN-VACC) to book appointments at supersites and pop-up clinics. Daily hours of operation are from 6:00 a.m. to 8:00 p.m.

Only individuals who are eligible can call or book an appointment online for immunization. You will be screened to ensure you meet current eligibility.





 

Medical Clinics and Pharmacies

The AstraZeneca/COVISHIELD vaccine is used to provide COVID-19 vaccines in doctors’ offices and pharmacies. Manitoba public health officials have developed guidance for the use of the AstraZeneca/Covishield vaccine.

If you are a senior or have mobility issues and need help getting to your appointment at a clinic or pharmacy, call 211 for available transportation options in your area.


Eligibility Criteria

Eligible Manitobans can find their nearest clinic or pharmacy with available doses by visiting: manitoba.ca/covid19/vaccine/finder.html

  • individuals aged 40 and over;
  • people aged 30 to 39 who meet one or more of the following conditions:
    • chronic renal disease including end stage renal disease undergoing hemodialysis OR peritoneal dialysis
    • chronic liver disease including cirrhosis due to any cause OR portal hypertension
    • chronic cardiovascular disease including heart failure, ventricular assist device, adult congenital heart disease coronary artery disease, malignant tachyarrythmia OR cardiomyopathies
      • COPD, pulmonary hypertension, pulmonary fibrosis, interstitial lung disease, severe/uncontrolled asthma OR cystic fibrosis
      • history of cerebral vascular accident with residual deficits
      • malignant hematologic disorders including leukemia and lymphoma OR clonal blood disorder
      • malignant neoplasms (solid tissue) who will receive or are currently receiving immunosuppressive therapy including chemotherapy
      • severe obesity (BMI ≥ 40)
      • receiving one or more of the following immunosuppressive therapies: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors, chronic dose prednisone >=20mg/day, mycophenolate, sulfasalazine and JAK inhibitors (e.g., tofacitinib)
      • solid organ or hematopoietic stem cell transplant (candidate or recipient)
      • trisomy 21 (Down’s syndrome)
      • asplenia or hyposplenism (including sickle cell disease)
    • chronic neurologic OR neurodevelopmental conditions including cerebral palsy, Parkinson’s disease, multiple sclerosis, ALS OR dementia (including Alzheimer’s disease)
    • HIV (CD4 cell count ≥ 200 x 106/L and CD4 percentage ≥ 15%)
    • severe systemic autoimmune disorders (e.g., systemic lupus erythematosus, scleroderma, myocarditis, rheumatoid arthritis)
    • type 1 or 2 diabetes mellitus (poorly controlled and/or with complications)
    • active tuberculosis (current or previous) OR current latent tuberculosis (LTBI)
    • receiving other immunosuppressing therapy
    • individuals receiving home care OR receiving any level of Community Living disABILITY Services supports (or as per family physician determination of equivalent levels of family support).



Second Dose Eligibility

Booking for second doses will begin May 22. Initially, only people who have the following priority conditions will be able to book a second dose appointment by phone or online:

  • receiving hemodialysis OR peritoneal dialysis
  • liver cirrhosis due to any cause OR portal hypertension
  • severe heart failure 
  • cancers including solid tumor and blood (leukemia/lymphoma) who will or are receiving chemotherapy, immunosuppressive therapy orimmune checkpoint inhibitors (e.g., nivolumab, pembrolizumab)
  • receiving one or more of the following medications: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors (cyclosporine, tacrolimus), chronic dose prednisone >=20mg/day, mycophenolate, and JAK inhibitors (e.g., tofacitinib)
  • have received or are on the list to receive a solid organ transplant
  • have received a stem cell transplant OR CAR-T therapy at least 3 months ago.
  • Down syndrome
  • Human immunodeficiency virus (HIV)
  • individuals receiving home care ≥ 4 times/week OR receiving 24/7 Community Living Disability Services supports (or as per family physician determination of equivalent levels of family support).